Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
August 12, 2020
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update
Jason H Karnes, Allan E Rettie, Andrew A Somogyi, et al.
Clinical Pharmacology and Therapeutics
|
November 18, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics
|
April 14, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT<sub>3</sub> Receptor Antagonists: 2026 Update
Claire Moore, Melissa S Bourque, Andreas Halman, et al.
Clinical Pharmacology and Therapeutics
|
June 12, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy
Katherine M Robinson, Seenae Eum, Zeruesenay Desta, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis
Jeffrey M Rybak, C Michael Dickens, Josie E Parker, et al.
Clinical Pharmacology and Therapeutics
|
January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
Craig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
Clinical Pharmacology and Therapeutics
|
April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Chad A Bousman, James M Stevenson, Laura B Ramsey, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update
Maud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics
|
July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy
Julio D Duarte, Cameron D Thomas, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy
Michael T Eadon, David W Hein, Michael A Andersen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
August 12, 2020
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update
Jason H Karnes, Allan E Rettie, Andrew A Somogyi, et al.
Clinical Pharmacology and Therapeutics
|
November 18, 2018
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
Mary V Relling, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics
|
April 14, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT<sub>3</sub> Receptor Antagonists: 2026 Update
Claire Moore, Melissa S Bourque, Andreas Halman, et al.
Clinical Pharmacology and Therapeutics
|
June 12, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy
Katherine M Robinson, Seenae Eum, Zeruesenay Desta, et al.
Antimicrobial Agents and Chemotherapy
|
June 21, 2017
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis
Jeffrey M Rybak, C Michael Dickens, Josie E Parker, et al.
Clinical Pharmacology and Therapeutics
|
January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
Craig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
Clinical Pharmacology and Therapeutics
|
April 9, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Chad A Bousman, James M Stevenson, Laura B Ramsey, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update
Maud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics
|
July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy
Julio D Duarte, Cameron D Thomas, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy
Michael T Eadon, David W Hein, Michael A Andersen, et al.
Page
of 5